Literature DB >> 15102760

Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis.

Terry Guthrie1, Simon Y C Wong, Bin Liang, Lisa Hyland, Sam Hou, E Arne Høiby, Svein Rune Andersen.   

Abstract

The mouse humoral immune response toward native or detergent-extracted outer membrane vesicles (NOMVs and DOMVs, respectively) from Neisseria meningitidis was determined after intranasal immunization. Both preparations elicited high frequencies of NOMV-specific antibody-forming cells (AFCs) locally in the nasal associated lymphoid tissue (NALT) after three or four weekly doses. The diffuse NALT (D-NALT) contained ca. 10-fold more NOMV-specific AFCs than those observed in the mediastinal lymph node, spleen, and bone marrow. AFCs observed in the D-NALT were primarily immunoglobulin A positive (IgA(+)) and were maintained for at least 1 month. In contrast, the organized NALT (O-NALT) contained low numbers of AFCs, and the response was relatively short-lived. In other lymphoid tissues, AFCs producing various IgG subclasses and IgM were present with IgG2b-producing AFCs being dominant or codominant with IgA or IgG2a. In serum and in all of the tissues examined, with the exception of the NALT, NOMVs clearly induced a stronger antibody response and a broader range of antibody isotypes than DOMVs. The development of NOMV-specific AFCs in spleen and bone marrow after intranasal immunization was slow compared to intravenous immunization but, once established, the intranasally elicited responses increased steadily for at least 75 days. NOMV-specific antibodies induced via several routes of immunization had high bactericidal activities in serum. Our results indicated that intranasally administered OMVs induced strong local and systemic antibody responses in mice that were relatively long-lived.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102760      PMCID: PMC387915          DOI: 10.1128/IAI.72.5.2528-2537.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.

Authors:  Rohit K Katial; Brenda L Brandt; Ellen E Moran; Stephen Marks; Victor Agnello; Wendell D Zollinger
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Nasal lymphoid tissue (NALT) as a mucosal immune inductive site.

Authors:  H Y Wu; H H Nguyen; M W Russell
Journal:  Scand J Immunol       Date:  1997-11       Impact factor: 3.487

Review 3.  Interaction of antigens and antibodies at mucosal surfaces.

Authors:  M E Lamm
Journal:  Annu Rev Microbiol       Date:  1997       Impact factor: 15.500

4.  Isolation and characterization of mouse nasal-associated lymphoid tissue.

Authors:  H Asanuma; A H Thompson; T Iwasaki; Y Sato; Y Inaba; C Aizawa; T Kurata; S Tamura
Journal:  J Immunol Methods       Date:  1997-03-28       Impact factor: 2.303

5.  Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue.

Authors:  H Y Wu; E B Nikolova; K W Beagley; M W Russell
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

6.  Novel in vitro model for high-rate IgA class switching.

Authors:  T M McIntyre; M R Kehry; C M Snapper
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

7.  Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response.

Authors:  S R Andersen; G Bjune; E A Høiby; T E Michaelsen; A Aase; U Rye; E Jantzen
Journal:  Vaccine       Date:  1997-08       Impact factor: 3.641

8.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines.

Authors:  S R Andersen; G Bjune; J Lyngby; K Bryn; E Jantzen
Journal:  Microb Pathog       Date:  1995-09       Impact factor: 3.738

10.  Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase.

Authors:  H Asanuma; Y Inaba; C Aizawa; T Kurata; S Tamura
Journal:  J Immunol Methods       Date:  1995-11-16       Impact factor: 2.303

View more
  7 in total

1.  Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination.

Authors:  Makda Fisseha; Ping Chen; Brenda Brandt; Todd Kijek; Elizabeth Moran; Wendell Zollinger
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 2.  Immune modulation by bacterial outer membrane vesicles.

Authors:  Maria Kaparakis-Liaskos; Richard L Ferrero
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

3.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

4.  Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants.

Authors:  Mark B Stoddard; Valerian Pinto; Paul B Keiser; Wendell Zollinger
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

Review 5.  Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body.

Authors:  Régis Stentz; Ana L Carvalho; Emily J Jones; Simon R Carding
Journal:  Biochem Soc Trans       Date:  2018-08-28       Impact factor: 5.407

6.  Neisseria meningitidis Factor H Binding Protein Surface Exposure on Salmonella Typhimurium GMMA Is Critical to Induce an Effective Immune Response against Both Diseases.

Authors:  Francesca Necchi; Giuseppe Stefanetti; Renzo Alfini; Elena Palmieri; Martina Carducci; Roberta Di Benedetto; Fabiola Schiavo; Maria Grazia Aruta; Fabiola Giusti; Ilaria Ferlenghi; Yun Shan Goh; Simona Rondini; Francesca Micoli
Journal:  Pathogens       Date:  2021-06-09

7.  Protection against neonatal enteric colibacillosis employing E. Coli-derived outer membrane vesicles in formulation and without vitamin D3.

Authors:  Babak Beikzadeh; Gholamreza Nikbakht Brujeni
Journal:  BMC Res Notes       Date:  2018-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.